Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 279
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03570021 | ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer | ||
| NCT05071001 | Long Term Brain Toxicity of Chemotherapy in Patients Treated for a Bone TumorDuring Childhood or Adolescence | ||
| NCT00910728 | Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative Diseases | ||
| NCT06479057 | PROACT is a Prospective Master Protocol for a Cohort Study Focused on Evaluating the Implementation of Integrated Proactive Supportive Care Pathways at Gustave Roussy | ||
| NCT02008734 | Randomized Phase II Study to Assess PD 0332991 in Breast Cancer | ||
| NCT06642844 | Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment | ||
| NCT01516580 | Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients | ||
| NCT05912075 | Preoperative Radiotherapy And ASTX660 in Rectum Cancer | ||
| NCT00349505 | Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma | ||
| NCT00949039 | Study Comparing Isolated Pelvic Perfusion With TNF-α 0.3 mg and Melphalan 1.5 mg/kg Versus Standard Treatment in Patients With Non Resectable, Recurrent Gynaecologic or Digestive Pelvic Cancer | ||
| NCT03314324 | A Study of Patient Preference Between ODM-201 and Enzalutamide in Men With Metastatic Castrate-resistant Prostate Cancer | ||
| NCT05705791 | Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma | ||
| NCT06298084 | Dose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer (ABC) After Progression on T-DXd | ||
| NCT04274868 | Pediatric Hepatic Tumors | ||
| NCT05705687 | Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors | ||
| NCT02063009 | Measurement of Cardiac Index Using an Implanted Central Venous Access Port in Patients Scheduled for Oncologic High-risk Surgery | ||
| NCT01557114 | Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant Melanoma | ||
| NCT04775121 | Classical Monocyte Kinetics in Chronic Myelomonocytic Leukemia | ||
| NCT05890781 | Engineering Immune Organoids to Study Pediatric Cancer | ||
| NCT03609112 | Neurocognitive Risks in Children With Solid Tumors | ||
| NCT03212469 | A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic Cancer | ||
| NCT00147160 | Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents | ||
| NCT00126230 | Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer | ||
| NCT03244956 | Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer | ||
| NCT00005062 | Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission | ||
| NCT02516774 | A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers | ||
| NCT00180947 | Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse | ||
| NCT06007092 | Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer | ||
| NCT02992912 | Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours | ||
| NCT02517125 | Evaluation of the Contribution of Transoral Robotic-assisted Surgery Using Da Vinci Xi for Head and Neck Tumors | ||
| NCT00126269 | Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary | ||
| NCT06505590 | STEpwise Research Program to Promote INGeniouS ONline Supportive Solutions in the Relief of Cancer-related Fatigue | ||
| NCT03366480 | A Study to Assess the Efficacy and Safety of ABTL0812 | ||
| NCT00162721 | The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas | ||
| NCT01289522 | Chemotherapy With Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | ||
| NCT01701479 | Long Term Continuous Infusion ch14.18/CHO Plus s.c. Aldesleukin (IL-2) | ||
| NCT03155386 | Optimized Angiomammography and Comparison With Standard Angiomammography | ||
| NCT00552149 | Biliary Cancers: EGFR INhibitor, Gemcitabine and Oxaliplatin | ||
| NCT02994576 | Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer | ||
| NCT00181025 | Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle | ||
| NCT00127049 | Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors | ||
| NCT00346645 | A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer | ||
| NCT02089100 | Trial of Superiority of Stereotactic Body Radiation Therapy in Patients With Breast Cancer | ||
| NCT04826432 | Pasireotide to Reduce Clinically Relevant Digestive Leakage After Complete Cytoreductive Surgery (CRS) Plus Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis | ||
| NCT01715363 | Feasibility of an Immediate Preoperative Chemotherapy Before Resection fo Colorectal Cancer | ||
| NCT02260739 | Sequential Analysis in Patients With an Hemopathy | ||
| NCT03984318 | Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs | ||
| NCT00180791 | High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood | ||
| NCT01834950 | Identification of Early Markers of Response and Resistance to Trastuzumab | ||
| NCT07016230 | Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB) |
